Sie suchten nach: combination tablet (Englisch - Maltesisch)

interaction not studied for this fixed dose combination tablet.
l-interazzjoni ma ġietx studjata għal din il-pillola ta’ kombinazzjoni b’doża fissa.

the combination tablet was absorbed in the body in the same way as the separate tablets
il- pillola tal- kombinazzjoni kienet assorbita fil- ġisem bl- istess mod bħall- pilloli separati.

test: single fixed-dose combination tablet taken under fasted conditions.
test: pillola ta’ kombinazzjoni ta’ doża fissa waħda taħt kundizzjonijiet ta’ sawm.

on day 3, those randomized to receive suboxone were switched to the combination tablet.
f’ jum 3, dawk li ntgħażlu b’ mod arbitrarju biex jirċievu suboxone inqalbu għall- pillola kombinata.

food had no effect on the pharmacokinetics of amlodipine or hydrochlorothiazide in the fixed combination tablet.
l-ikel ma kellu l-ebda effett fuq il-farmakokinetiċi ta’ amlodipine jew hydrochlorothiazide fil-pillola b’kombinazzjoni fissa.

the patient may need to take separate tablets or capsules before switching to the combination tablet.
huwa possibbli li, qabel ma jaqleb għall- pillola li fiha iż- żewġ sustanzi attivi, il - pazjent ikollu jieħu pilloli jew kapsuli separati.

on day 3, those randomized to receive buprenorphine/naloxone were switched to the combination tablet.
f’jum 3, dawk li ntgħażlu b’mod każwali biex jirċievu buprenorphine/naloxone, inqalbu għall-pillola kombinata.

4 study conducted with emtricitabine/rilpivirine/tenofovir alafenamide fixed-dose combination tablet.
4 l-istudju twettaq bil-pillola kombinata ta’ doża fissa ta’ emtricitabine/rilpivirine/tenofovir alafenamide.

even a light meal improves absorption of tenofovir from the combination tablet (see section 5.2).
anke ikla ħafifa ttejjeb l- assorbiment ta ’ tenofovir mill- pillola kombinata taż- żewġ mediċini (ara sezzjoni 5. 2).

consistent with the monotherapy formulation, food had no effect on the pharmacokinetics of amlodipine in the fixed combination tablet.
b’mod konsistenti mal-formulazzjoni tal-mediċina waħedha, l-ikel ma kellu l-ebda effett fuq il- farmakokinetika ta’ amlodipine fil-pillola b’taħlita fissa.

the combination tablet was absorbed in the body in the same way as the separate medicines, when they were taken without food.
il-pillola kombinata ġiet assorbita fil-ġisem bl-istess mod bħall-mediċini separati, meta ttieħdu mingħajr ikel.

3 study conducted with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fixed-dose combination tablet.
3 studju twettaq b’pillola kombinata ta’ doża fissa ta’ elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.

fosavance is a combination tablet containing the two active substances alendronate sodium trihydrate and colecalciferol (vitamin d3).
fosavance hija pillola kombinata li fiha ż-żewġ sustanzi attivi alendronate sodium trihydrate u colecalciferol (vitamina d3).

the alendronate component in the adrovance (70mg/ 5600 iu) combination tablet is bioequivalent to the alendronate 70 mg tablet.
il- komponent alendronate fil- pillola kombinata adrovance (70 mg/ 5600 iu) huwa bijoekwivalenti għal pillola ta ’ 70 mg alendronate.

co-administration of efavirenz with the fixed combination tablet containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate is not recommended.
l- għoti flimkien ta ’ efavirenz mal- pillola ta ’ kombinazzjoni fissa li fiha efavirenz, emtricitabine, u tenofovir disoproxil fumarate, mhuwiex rakkomandat.

1 this study was conducted using the fixed-dose combination tablet elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil.
1 dan l-istudju sar bl-użu ta’ pillola ta’ kombinazzjoni ta’ doża fissa ta’ elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil.

for convenience, patients receiving aliskiren and hydrochlorothiazide from separate tablets may be switched to a fixed combination tablet of rasilez hct containing the same component doses.
għall-konvenjenza, pazjenti li jkunu qed jirċievu aliskiren u hydrochlorothiazide minn pilloli separati jistgħu jinqalbu għall-pillola ta’ taħlita fissa ta’ rasilez hct li fiha l-istess dożi tal-komponenti.

lamivudine in the fixed- dose combination tablet was bioequivalent with the lamivudine (single agent) after administration of the individual component.
lamivudine fil-pillola kombinata b’doża fissa kien bijoekwivalenti għal lamivudine (aġent uniku) wara l-għoti tal-komponent individwali.

the fixed-dose combination tablet of abacavir/lamivudine (fdc) has been shown to be bioequivalent to lamivudine and abacavir administered separately.
il-pillola kombinata b’doża fissa ta’ abacavir/lamivudine (fdc) ġiet ppruvat li hi bijoekwivalenti għal lamivudine u abacavir meħudin separatament.

maraviroc the combination tablet containing efavirenz, emtricitabine and tenofovir should not be taken with stocrin unless recommended by your doctor since it contains efavirenz, the active ingredient of stocrin.
maraviroc il-pillola ta’ kombinazzjoni li fiha efavirenz, emtricitabine u tenofovir ma għandhiex tittieħed ma’ stocrin, sakemm dan ma jkunx rakkomandat mit-tabib tiegħek, minħabba li din fiha efavirenz, is-sustanza attiva ta’ stocrin.